Vidofludimus Calcium Thwarts Disability Progression & The MS Hug

Nov 30, 2022, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how relapsing-remitting MS patients have not had a confirmed disability progression following two years of treatment with vidofludimus calcium.

He also reads “The MS Hug: A Frightening Embrace You’d Rather Not Have” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/